Services on Demand
Journal
Article
Spanish (pdf)
Article in xml format
Article references
Automatic translation
Send this article by e-mailIndicators
Cited by SciELO 
Access statistics
Related links
Similars in
SciELO
Share
Permalink
Revista mexicana de urología
On-line version ISSN 2007-4085Print version ISSN 0185-4542
Abstract
ARANA-CARRERA, Anaís de Lourdes and MORALES-RAMOS, Víctor Manuel. Review of the application of photoselective vaporization in benign hyperplasia of the prostate. Rev. mex. urol. [online]. 2021, vol.81, n.3, e06. Epub Apr 14, 2023. ISSN 2007-4085. https://doi.org/10.48193/rmu.v81i3.702.
Benign prostatic hyperplasia is the most frequent benign tumor in men, reaching a prevalence of 40% in the fourth decade of life and 80% in men 80 years of age and older. The condition leads to bothersome and incapacitating lower urinary tract symptoms that are currently measured by the International Prostate Symptom Score. At present, there are different alternatives for minimally invasive surgical treatment, such as GreenLight laser photoselective vaporization, that can provide the same benefits for the patient as conventional treatment options.
Methods:
To find out and describe the usefulness and safety of photoselective vaporization in patients with benign prostatic hyperplasia, a search for information published within the last 10 years was conducted on the PubMed, ScienceDirect, BVS, and ClinicalKey databases, resulting in the selection of 11 notable studies.
Conclusion:
GreenLight laser photoselective vaporization is a safe and efficacious alternative for managing the symptoms of benign prostatic hyperplasia, in the short term and long term, with a lower risk of complications than transurethral resection of the prostate.
Keywords : Benign prostatic hyperplasia (BPH); Transurethral resection of the prostate (TURP); Photoselective vaporization; Efficacy.
